Montgomery, R Bruce <br/><br/>
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.  [electronic resource] 

 -  Cancer  Sep 2007 
 - 996-1002 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.22917  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Diarrhea--chemically induced<br/>Diethylstilbestrol--administration & dosage<br/>Drug Administration Schedule<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Paclitaxel--administration & dosage<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Treatment Outcome<br/>Tubulin Modulators--administration & dosage<br/>Venous Thrombosis--chemically induced